Flurazepam

CAS: 17617-23-1
Molecular Formula: C21H23ClFN3O
Molecular Weight: 387.8782
Product description:This product with drug addiction and other possible addiction share, increase the risk of addiction. Drinking and with general anesthetics, clonidine, analgesic, monoamine oxidase inhibiting drugs and share, tricyclic antidepressants can mutual synergy. And share the antacids can delay the absorption of this product. This product with antihypertensive drugs or and diuresis antihypertensive agents used, can make the antihypertensive effect increased. This product with calcium channel blockers and other blood pressure medicines, can make its antihypertensive effect increased. This product and share with cimetidine can inhibit the liver metabolism, thus make clear slowed, blood drug concentration increased. This product and propranolol share can cause epileptic seizure type and (or) frequency change, should timely adjust the dosage. This product with carbamazepine share, because both the liver microsomal enzymes induced can make blood drug concentration to drop, clear shorten half-life. When this product with levodopa share, can reduce the effectiveness of the latter.